AGP Executive Report
Last update: 10 hours agoCancer Advances: ESMO reports several promising survival gains. Long-term prostate cancer trial data found abiraterone extended median survival to 6.1 years, versus 4.6 years with standard care; divarasib also outperformed two existing drugs in KRAS-mutated lung cancer. Ebola Response: Nigeria is paying people in isolation or quarantine N100,000 a week to help cover living costs after an imported case was confirmed in Abuja. Lagos says it is stepping up surveillance and airport screening; no cases have been reported there. Reproductive Health: South Korea plans to allow medication abortion in 2027, but proposed rules—including a nine-week limit for the first two years—could restrict access. In Australia, a trial starting in January will expand subsidized pharmacy access to contraception and UTI treatment, prompting concerns about missed diagnoses and unnecessary antibiotics.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.